IL137859A0 - Use of retinoic acid activity inhibitors to slow down hair loss - Google Patents

Use of retinoic acid activity inhibitors to slow down hair loss

Info

Publication number
IL137859A0
IL137859A0 IL13785999A IL13785999A IL137859A0 IL 137859 A0 IL137859 A0 IL 137859A0 IL 13785999 A IL13785999 A IL 13785999A IL 13785999 A IL13785999 A IL 13785999A IL 137859 A0 IL137859 A0 IL 137859A0
Authority
IL
Israel
Prior art keywords
slow down
retinoic acid
hair loss
acid activity
activity inhibitors
Prior art date
Application number
IL13785999A
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of IL137859A0 publication Critical patent/IL137859A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13785999A 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss IL137859A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (en) 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY
PCT/FR1999/000687 WO1999049838A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss

Publications (1)

Publication Number Publication Date
IL137859A0 true IL137859A0 (en) 2001-10-31

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13785999A IL137859A0 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss

Country Status (16)

Country Link
EP (1) EP1066017A1 (en)
JP (1) JP2002509870A (en)
KR (1) KR20010042104A (en)
CN (1) CN1298290A (en)
AR (1) AR015551A1 (en)
AU (1) AU2938899A (en)
BR (1) BR9908411A (en)
CA (1) CA2324899A1 (en)
FR (1) FR2776511B1 (en)
HU (1) HUP0102411A3 (en)
IL (1) IL137859A0 (en)
NO (1) NO20004880L (en)
PL (1) PL343004A1 (en)
RU (1) RU2193877C2 (en)
WO (1) WO1999049838A1 (en)
ZA (1) ZA200004483B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (en) * 1995-05-03 1997-05-30 Cird Galderma USE OF RETINOIDS IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION
FR2739777B1 (en) * 1995-10-11 1997-11-14 Cird Galderma LIGAND ANTAGONIST RAR-GAMMA OR AGONIST RAR-ALPHA AS AN APOPTOSIS INHIBITOR
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
CN1255396C (en) * 1996-03-18 2006-05-10 卫材株式会社 Carboxylic acid derivatives having fused rings

Also Published As

Publication number Publication date
HUP0102411A2 (en) 2001-11-28
KR20010042104A (en) 2001-05-25
CN1298290A (en) 2001-06-06
JP2002509870A (en) 2002-04-02
BR9908411A (en) 2000-12-05
CA2324899A1 (en) 1999-10-07
PL343004A1 (en) 2001-07-30
NO20004880L (en) 2000-11-30
AR015551A1 (en) 2001-05-02
ZA200004483B (en) 2002-02-27
AU2938899A (en) 1999-10-18
HUP0102411A3 (en) 2002-12-28
RU2193877C2 (en) 2002-12-10
WO1999049838A1 (en) 1999-10-07
EP1066017A1 (en) 2001-01-10
FR2776511B1 (en) 2001-05-11
FR2776511A1 (en) 1999-10-01
NO20004880D0 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
PL328871A1 (en) Substituted derivatives of 4-hydroxyphenyloalcanic acid exhibiting antagonistic activity in respect to ppar-gamma
PL341059A1 (en) Mimetic anilides of retinoic acid
HRP20000201B1 (en) Prostaglandin agonists and their use to treat bone disorders
AU2592699A (en) Introduction of nucleic acid into skin cells by topical application
PL338633A1 (en) Derivatives of aryloxyarylsuphonylamino hydroxamic acid
PL335027A1 (en) Derivatives of arylsulphonylamino hydroxamic acid
AU2001290936A1 (en) Application of water nanoclusters to skin
AU2001278006A1 (en) Agonists of follicle stimulating hormone activity
DE69934510D1 (en) REDUCTION OF HAIR GROWTH
DE69813935D1 (en) Use of retinoids to induce skin pigmentation
DE69825607D1 (en) REDUCTION OF HAIR GROWTH
PL332430A1 (en) Skin care compositions containing combinations of compounds capable to simulate the action of retinic acid onto skin
AU4306197A (en) Use of inhibitors of the activity of retinoic acid to promote healing
GB9807464D0 (en) Purification of human acid µ-glucosidase
AU5087999A (en) Acid/irritant neutralization of skin
PL351986A1 (en) Method of reducing il-5 activity
EP1007036A4 (en) Methods of using butyric acid or butyric acid derivatives to protect against hair loss
HK1045260B (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
EP1109582A4 (en) Methods to enhance and confine expression of genes
ZA879063B (en) Use of 13-cis retinoic acid
IL137859A0 (en) Use of retinoic acid activity inhibitors to slow down hair loss
AU8398398A (en) Modification of nitric oxide activity to treat fas-induced pathologies
AU2500997A (en) Use of prostaglandins to treat ataxia telangiectasia
EP1150671A4 (en) Use of pyrethroid compounds to promote hair growth
AU3063899A (en) Use of il-10 to treat major depressive disorder